The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting the TGFß signaling pathway to mitigate tumor metastasis in 9p21-loss urothelial bladder cancer.
 
Cindy Jiang
No Relationships to Disclose
 
Yuxue Zhang
No Relationships to Disclose
 
Kai Yu
No Relationships to Disclose
 
Ying Mei
No Relationships to Disclose
 
Wei Qiao
No Relationships to Disclose
 
Mohammad Jad Moussa
No Relationships to Disclose
 
Jianfeng Chen
No Relationships to Disclose
 
Raymond Wang
No Relationships to Disclose
 
Jianping Zhao
No Relationships to Disclose
 
Amishi Shah
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Exelixis; Pfizer/EMD Serono
Research Funding - 4D Pharma (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); EMD Serono (Inst)
 
Sangeeta Goswami
No Relationships to Disclose
 
Charles Guo
No Relationships to Disclose
 
Arlene Siefker-Radtke
Consulting or Advisory Role - AstraZeneca/Merck; Basilea Pharmaceutical; Bavarian Nordic; Bristol Myers Squibb Foundation; G1 Therapeutics; Genentech; Gilead Sciences; IDEAYA Biosciences; Immunomedics; Janssen; Mirati Therapeutics; Nektar; Seagen; Taiho Pharmaceutical
Research Funding - Basilea (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Nektar (Inst); NIH/NCI (Inst)
Patents, Royalties, Other Intellectual Property - Methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer
 
Matthew Campbell
Honoraria - Curio Science; Eisai; Exelixis; MJH Life Sciences; OnViv; Seagen; Targeted Oncology
Research Funding - Apricity Health (Inst); Aravive (Inst); Exelixis (Inst); Janssen Oncology (Inst); Pfizer/EMD Serono (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - Exelixis; SeaGen
 
Linghua Wang
No Relationships to Disclose
 
Omar Alhalabi
Consulting or Advisory Role - Adaptimmune; Bicycle Therapeutics; Cardinal Health; Seagen; Silverback Therapeutics
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Genentech (Inst); Ikena Oncology (Inst)
 
Jianjun Gao
Consulting or Advisory Role - AstraZeneca; AstraZeneca; crispr therapeutics; Infinity Pharmaceuticals; Janssen; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca